BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25723987)

  • 1. Reorienting the HIV response in Niger toward sex work interventions: from better evidence to targeted and expanded practice.
    Fraser N; Kerr CC; Harouna Z; Alhousseini Z; Cheikh N; Gray R; Shattock A; Wilson DP; Haacker M; Shubber Z; Masaki E; Karamoko D; Görgens M
    J Acquir Immune Defic Syndr; 2015 Mar; 68 Suppl 2():S213-20. PubMed ID: 25723987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programmes for seasonal migrant labourers.
    Kelly SL; Shattock AJ; Kerr CC; Stuart RM; Papoyan A; Grigoryan T; Hovhannisyan R; Grigoryan S; Benedikt C; Wilson DP
    J Int AIDS Soc; 2016; 19(1):20772. PubMed ID: 27281790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies.
    Shattock AJ; Benedikt C; Bokazhanova A; Đurić P; Petrenko I; Ganina L; Kelly SL; Stuart RM; Kerr CC; Vinichenko T; Zhang S; Hamelmann C; Manova M; Masaki E; Wilson DP; Gray RT
    PLoS One; 2017; 12(2):e0169530. PubMed ID: 28207809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of providing HIV care and optimal allocation of HIV resources in Guyana.
    Suraratdecha C; Stuart RM; Edwards M; Moore R; Liu N; Wilson DP; Albalak R
    PLoS One; 2020; 15(10):e0238499. PubMed ID: 33119591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal allocation of HIV resources among geographical regions.
    Kedziora DJ; Stuart RM; Pearson J; Latypov A; Dierst-Davies R; Duda M; Avaliani N; Wilson DP; Kerr CC
    BMC Public Health; 2019 Nov; 19(1):1509. PubMed ID: 31718603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs.
    Benedikt C; Kelly SL; Wilson D; Wilson DP;
    Int J Drug Policy; 2016 Dec; 38():73-80. PubMed ID: 27883944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study.
    McGillen JB; Anderson SJ; Dybul MR; Hallett TB
    Lancet HIV; 2016 Sep; 3(9):e441-e448. PubMed ID: 27562745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact and Cost of the HIV/AIDS National Strategic Plan for Mozambique, 2015-2019--Projections with the Spectrum/Goals Model.
    Korenromp EL; Gobet B; Fazito E; Lara J; Bollinger L; Stover J
    PLoS One; 2015; 10(11):e0142908. PubMed ID: 26565696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource Optimization.
    Kerr CC; Stuart RM; Gray RT; Shattock AJ; Fraser-Hurt N; Benedikt C; Haacker M; Berdnikov M; Mahmood AM; Jaber SA; Gorgens M; Wilson DP
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):365-76. PubMed ID: 25803164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.
    Stuart RM; Grobicki L; Haghparast-Bidgoli H; Panovska-Griffiths J; Skordis J; Keiser O; Estill J; Baranczuk Z; Kelly SL; Reporter I; Kedziora DJ; Shattock AJ; Petravic J; Hussain SA; Grantham KL; Gray RT; Yap XF; Martin-Hughes R; Benedikt CJ; Fraser-Hurt N; Masaki E; Wilson DJ; Gorgens M; Mziray E; Cheikh N; Shubber Z; Kerr CC; Wilson DP
    J Int AIDS Soc; 2018 Apr; 21(4):e25097. PubMed ID: 29652100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model for allocating CDC's HIV prevention resources in the United States.
    Lasry A; Sansom SL; Hicks KA; Uzunangelov V
    Health Care Manag Sci; 2011 Mar; 14(1):115-24. PubMed ID: 21184183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV prevention where it is needed most: comparison of strategies for the geographical allocation of interventions.
    Anderson SJ; Ghys PD; Ombam R; Hallett TB
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29220115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The size and distribution of key populations at greater risk of HIV in Pakistan: implications for resource allocation for scaling up HIV prevention programmes.
    Emmanuel F; Thompson LH; Salim M; Akhtar N; Reza TE; Hafeez H; Ahmed S; Blanchard JF
    Sex Transm Infect; 2013 Sep; 89 Suppl 2(Suppl 2):ii11-7. PubMed ID: 23843454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study.
    Cremin I; McKinnon L; Kimani J; Cherutich P; Gakii G; Muriuki F; Kripke K; Hecht R; Kiragu M; Smith J; Hinsley W; Gelmon L; Hallett TB
    Lancet HIV; 2017 May; 4(5):e214-e222. PubMed ID: 28233660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocations.
    Shattock AJ; Kerr CC; Stuart RM; Masaki E; Fraser N; Benedikt C; Gorgens M; Wilson DP; Gray RT
    J Int AIDS Soc; 2016; 19(1):20627. PubMed ID: 26928810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Looking upstream to prevent HIV transmission: can interventions with sex workers alter the course of HIV epidemics in Africa as they did in Asia?
    Steen R; Hontelez JA; Veraart A; White RG; de Vlas SJ
    AIDS; 2014 Mar; 28(6):891-9. PubMed ID: 24401648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Accelerated HIV Response Scenarios in Côte d'Ivoire.
    Maheu-Giroux M; Diabaté S; Boily MC; Jean-Paul N; Vesga JF; Baral S; Abo K; Wognin V; Diouf D; Alary M
    J Acquir Immune Defic Syndr; 2019 Apr; 80(5):503-512. PubMed ID: 30649034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal investment in a portfolio of HIV prevention programs.
    Zaric GS; Brandeau ML
    Med Decis Making; 2001; 21(5):391-408. PubMed ID: 11575489
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.